International Assets Investment Management’s Roivant Sciences ROIV Stock Holding History

International Assets Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	+6,825	New	+$202K	0.01%	788

Other funds holding ROIV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PSC

Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

International Assets Investment Management's ROIV Position: Q2 2026 in Review

International Assets Investment Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 6,825 shares worth $239K. The stake represents 0.01% of the portfolio and ranks #788 among its holdings.

301 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

International Assets Investment Management held 6,825 shares of Roivant Sciences worth $239K as of Q2 2026.
Roivant Sciences was a new International Assets Investment Management position in Q2 2026.
Roivant Sciences made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #788 holding.
301 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.